Clinical Trial Update: Phase 2 Sequential and Concurrent Chemoradiation for Advanced Nasopharyngeal Carcinoma (NPC) [Phase 2]

View source ↗

Summary

Phase 2 trial update on sequential and concurrent chemoradiation for advanced nasopharyngeal carcinoma has completed enrollment with results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Cancer

Snippet

Sponsor: Stanford University | Conditions: Stage II Lymphoepithelioma of the Nasopharynx, Stage II Squamous Cell Carcinoma of the Nasopharynx | Phase 2 | Status: COMPLETED | Results posted: 2021-04-06